Annual Retained Earnings
-$349.50 M
-$80.05 M-29.71%
31 December 2021
Summary:
Concert Pharmaceuticals annual retained earnings is currently -$349.50 million, with the most recent change of -$80.05 million (-29.71%) on 31 December 2021. During the last 3 years, it has fallen by -$80.05 million (-29.71%).CNCE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$440.05 M
-$28.78 M-7.00%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly retained earnings is currently -$440.05 million, with the most recent change of -$28.78 million (-7.00%) on 30 September 2022.CNCE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -29.7% | -40.4% |
| 5 y5 years | -200.0% | -152.6% |
CNCE Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | +358.4% | +577.5% |
Concert Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -$440.05 M(+7.0%) |
| June 2022 | - | -$411.27 M(+6.2%) |
| Mar 2022 | - | -$387.23 M(+10.8%) |
| Dec 2021 | -$349.50 M(+29.7%) | -$349.50 M(+11.5%) |
| Sept 2021 | - | -$313.37 M(+9.3%) |
| June 2021 | - | -$286.69 M(-1.9%) |
| Mar 2021 | - | -$292.12 M(+8.4%) |
| Dec 2020 | -$269.45 M(+38.4%) | -$269.45 M(+9.1%) |
| Sept 2020 | - | -$247.06 M(+8.3%) |
| June 2020 | - | -$228.15 M(+6.0%) |
| Mar 2020 | - | -$215.16 M(+10.5%) |
| Dec 2019 | -$194.68 M(+67.1%) | -$194.68 M(+11.8%) |
| Sept 2019 | - | -$174.19 M(+10.9%) |
| June 2019 | - | -$157.01 M(+13.5%) |
| Mar 2019 | - | -$138.34 M(+18.7%) |
| Dec 2018 | -$116.52 M(+52.8%) | -$116.52 M(+21.8%) |
| Sept 2018 | - | -$95.67 M(+22.2%) |
| June 2018 | - | -$78.28 M(+20.5%) |
| Mar 2018 | - | -$64.95 M(-14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | -$76.24 M(-55.6%) | -$76.24 M(+8.6%) |
| Sept 2017 | - | -$70.18 M(-64.6%) |
| June 2017 | - | -$198.24 M(+7.0%) |
| Mar 2017 | - | -$185.22 M(+7.8%) |
| Dec 2016 | -$171.88 M(+41.9%) | -$171.88 M(+7.5%) |
| Sept 2016 | - | -$159.84 M(+7.6%) |
| June 2016 | - | -$148.48 M(+10.0%) |
| Mar 2016 | - | -$135.04 M(+11.5%) |
| Dec 2015 | -$121.16 M(-16.6%) | -$121.16 M(-0.6%) |
| Sept 2015 | - | -$121.85 M(+7.6%) |
| June 2015 | - | -$113.29 M(-26.6%) |
| Mar 2015 | - | -$154.34 M(+6.2%) |
| Dec 2014 | -$145.34 M(+27.9%) | -$145.34 M(+6.5%) |
| Sept 2014 | - | -$136.41 M(+6.1%) |
| June 2014 | - | -$128.58 M(+6.6%) |
| Mar 2014 | - | -$120.59 M(+6.1%) |
| Dec 2013 | -$113.64 M(+5.6%) | -$113.64 M(+5.5%) |
| Sept 2013 | - | -$107.72 M(+0.1%) |
| Dec 2012 | -$107.58 M(+23.5%) | -$107.58 M |
| Dec 2011 | -$87.14 M | - |
FAQ
- What is Concert Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual retained earnings?
The current annual retained earnings of CNCE is -$349.50 M
What is the all time high annual retained earnings for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual retained earnings is -$76.24 M
What is Concert Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of CNCE is -$440.05 M
What is the all time high quarterly retained earnings for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly retained earnings is -$64.95 M